期刊文献+

γ干扰素体外诱导骨髓间充质干细胞的IDO表达及其免疫调节作用 被引量:1

γ-interferon-induced IDO expression of mesenchymal stem cells in vitro and the immuno-regulatory mechanism
原文传递
导出
摘要 目的探讨γ干扰素(IFN-γ)体外诱导作用成人骨髓间充质干细胞(MSCs)的吲哚胺2,3-过氧化酶(IDO)的表达及IDO对异基因T淋巴细胞增殖的影响。方法从人骨髓中分离、培养MSCs,观察传代3次以上的细胞形态,应用流式细胞术检测其表面标志,以鉴定其纯度。分别用浓度为0、20、50、100、200U/ml的IFN-γ诱导作用MSCs后,以逆转录聚合酶链反应检测IDOmRNA的表达,蛋白印迹法检测IDO蛋白的表达,反相高效液相色谱法检测色氨酸的特异代谢产物犬尿氨酸的特异代谢率,以此判断IDO的活性。以丝裂霉素C灭活的外周血单个核细胞为刺激细胞,异基因T淋巴细胞为反应细胞,与经200U/ml IFN-γ作用的MSCs组成混合淋巴细胞培养体系,MSCs与反应细胞的比例分别为1:5、1:10、1:50及1:100,部分混合淋巴细胞培养体系中加入IDO的特异性抑制剂1-甲基色氨酸(1-MT),检测T淋巴细胞增殖率及培养体系中IDO活性。结果MSCs培养传代3代以后的纯度达到95%。在无IFN-γ作用时,MSCs没有IDO mRNA表达,经不同浓度的IFN-γ诱导后,均可检测到IDOmRNA表达,且表达强度呈IFN-γ剂量依赖性;IDO蛋白的表达与IDOmRNA一致;随着IFN-γ浓度的增加,MSCs培养上清液中的色氨酸浓度降低,而犬尿氨酸浓度升高。在无MSCs的混合淋巴细胞培养体系中,T淋巴细胞的增殖率为(80.2±5.7)%,当MSCs与反应细胞之比为1:5、1:10、1:50及1:100时,T淋巴细胞的增殖率分别为(28.1±3.2)%、(38.6±4.0)%、(57.2±2.5)%和(84.1±4.6)%,若在相同的混合淋巴细胞培养体系中加入1-MT,则MSCs对T淋巴细胞增殖的抑制作用基本消失;培养体系中IDO的活性与MSCs的数量成正比。结论γ干扰素在体外能诱导MSCs的IDO表达,其表达水平与γ干扰素呈剂量依赖性;IDO能抑制T淋巴细胞增殖。 Objective To study the effect of y-interferon (IFN-γ) on the IDO expression of mesenchymal stem cells (MSCs) and the effect of IDO activity in MSCs on allogeneic T-lymphocyte proliferation, and explore the immuno-regulatory mechanism of MSCs. Methods MSCs were isolated and cultured from human bone marrow cells. The morphology of more than 3 passage MSCs was observed by microphotograph, and the purity of MSCs was identified with phenotypes tested by flow cytometry. The expression of IDO mRNA and protein and IDO functional activity in MSCs induced by IFN-γ at various concentrations (0, 20, 50, 100, 200 U/ml) were detected by RT-PCR method, Western blot method and HPLC method respectively. MLRs cultures were set up with mitomycin C-treated human peripheral blood mononuclear cells (PBMCs) as stimulators and human allogeneic T- lymphocytes as responder cells. In MSCs/MLRs coculture experiments, MLRs were performed on a layer of 1×10^5s, 5×10^4, 1×10^4 or 5×10^3 MSCs (MSCs:responderTcells =1:5, 1:10, 1:50, 1: 100) in the presence or absence of 1-methyl-D-trytophan (1-MT). T-lymphocytes proliferation and IDO activity in coculture supernatant were determined. Results The expression of IDO mRNA and protein expression and IDO functional activity were found in MSCs induced by IFN-γ, and the amount of expression and ff)O activity were increased gradually with the increases of concentrations of IFN-γ; When cocultured with 1 × 10^5 , 5 × 10^4, 1 × 10^4 MSCs (MSCs: responder T cells = 1:5, 1 : 10, 1:50), T-lymphocytes proliferation was decreased apparently and ff)O activity increased obviously as compared with control group (P〈0. 05). In parallel experiments, 1-MT was added. T-lymphocytes proliferation and ff)O activity restored partially. While cocultured with 5 × 10^3 MSCs (MSCs: responder T cells = 1 : 100) T-lymphocytes proliferation was raised slightly and IDO activity had no change as compared with control group (P〉0. 05). Conclusion IFN-γ could induce the expression of IDO of MSCs in vitro. IDO could inhibit the T-lymphocyte proliferation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2007年第3期133-137,共5页 Chinese Journal of Organ Transplantation
基金 湖北省科技攻关计划(2005AK 041103)
关键词 间质干细胞 吲哚胺2 3-过氧化酶 T淋巴细胞 干扰素Ⅱ型 Mesenchymal stem cells Indoleamine 2,3-dioxygenase T-Lymphocytes Interferon type Ⅱ
  • 相关文献

参考文献7

  • 1Spees JL, Olson SD, Ylostalo J, et al. Differentiation, cell fusion and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA, 2003, 100(23) :2397-2402.
  • 2Wang D, Park JS, Chu JS, et al. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor betal stimulation. J Biol Chem, 2004, 279(42) :43725-43734.
  • 3Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002, 30( 1 ) : 42248.
  • 4Frassoni F, Labopin M, Bacigalupo A, et al. Expanded mesnchymal stem cells(MSC), coinfused with HLA identical hemapoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant, 2002, 29 Suppl 2:S2.
  • 5Fibbe WE, Coort WA. Mesenchyrnal stem cells and hematopoietic stem cell transplantation. Ann N Y Acad Sci, 2003,996(3): 235-244.
  • 6Munn DH, Shafizadeh E, Attwood JT, et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med, 1999, 189(9):1363-1372.
  • 7Miwa N, Hayakawa S, Miyazaki S, et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferongamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod, 2005, 11 (12) :865-870.

同被引文献9

  • 1戴向晨,刘彤,朱理玮,王鹏志.小鼠小肠移植术前输注表达吲哚胺2,3双加氧酶的供者树突细胞抑制排斥反应[J].中华器官移植杂志,2007,28(2):74-77. 被引量:4
  • 2Heitger A. Regulation of expression and function of I130 in human dendritic cells[J]. Curr Med Chem, 2011, 18 (15) : 2222-2233.
  • 3Agrawal A, Sridharan A, Prakash S, et al. Dendritic cells and aging: consequences for autoimmunity [J ]. Expert Rev Clin Immunol, 2012, 8(1 ) :73-80.
  • 4Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists[J]. Hum Irnmunol, 2009, 70(5):345-352. 0.
  • 5Onishi Y, Fehervari Z, Yamaguehi T, et al. Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation l,J ]. Proe Nail Acad Sci U S A, 2008, 105(29):1(1113-10118.
  • 6Fukunaga M, Yamamoto Y, Kawasoe M, et ak Studies on tissue and cellular distribution of indoleamine 2, 3-dioxygenase 2: the absence of IIN)I upregulates IDO2 expre~ssion in the epididymis l-J]. J Histochem Cytoehern, 2012, 6(1(11 ) :854-8611.
  • 7Bai X, Zhu BT. Indolearnine 2, 3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functionsl,J]. J Histochem Cytochern, 2010, 58(1 ) : 17-28.
  • 8Tan PH, Beutelspacher SC, Xue SA, et al. Modulation of human dendritic-cell function following transduetion with viral vectors: implications for gene therapyl,J]. Blood, 2005, 1(~5 (10) :3824-3832.
  • 9Munn DH, Sharma ME), Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3- dioxygenasel,J]. Science, 2002, 297(5588): 1867-187.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部